Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Decide which cash back credit card you should get by assessing your spending habits. Find the best rewards for you.
27,595 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
A high-profile former AI czar challenges Sanders’ 50% government stake plan for AI firms, warning that nationalizatio...
Astera Labs stock skyrocketed last month as multiple catalysts converged. This deep-dive breaks down the driving forc...
When a local emergency provider faces a court case over funds, it isn’t just a headline—it can affect budgets, bills,...
Duolingo built a global audience by offering free lessons and charging a devoted subset of users. As growth slows, in...
Gas prices have moved sharply, with a $0.48 jump in one week. This article breaks down the reasons behind the move, w...
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...
A memory themed ETF is drawing intense inflows, triggering questions about momentum versus risk. This guide breaks do...
Meta's plan to price AR glasses at $300 could be a turning point for investors. This article breaks down the potentia...
U.S. stocks rise as inflation remains stubborn, oil prices jump, and growth slows. The Nasdaq Composite leads gains a...
Investors poured into Ripple ETFs at the strongest pace in months, pushing cumulative inflows toward new records. Yet...